Ending Medicaid Funding for Child Sex-Change Procedures: Protecting Children and Prioritizing Evidence-Based Care
American taxpayers will no longer fund child sex-change hormones or surgeries as the Centers for Medicare & Medicaid Services (CMS) announced the cessation of Medicaid funding for such procedures. The decision aims to protect children from experimental and risky sex-rejecting procedures lacking reliable clinical benefits. The Children’s Health Insurance Program (CHIP) will also stop covering sex-change hormones and surgeries. Mental health treatments for gender dysmorphia and other conditions will remain covered under Medicaid and CHIP.
Conservatives criticized previous policies that allowed federal funding for therapies and procedures enabling children to transition physically before reaching legal milestones. The new rule excludes coverage for cross-sex hormones, puberty blockers, and sex-change surgeries due to potential irreversible harm, including infertility, impaired sexual function, and altered brain development. Secretary Robert F. Kennedy Jr. reviewed research on sex-change procedures in minors, leading to the decision to end federal taxpayer-funded procedures.
The decision to halt funding for sex-rejecting procedures on children is based on significant evidence gaps and safety concerns identified in research. The United Kingdom's Cass Review highlighted the limited and inconclusive evidence on medical interventions like cross-sex hormones and puberty blockers. The Trump Administration emphasizes evidence-based care to protect children's long-term health and ensure taxpayer dollars support interventions with proven benefits. The transition period allows children currently receiving hormone treatments to continue funding for six months after the new rule's implementation.
In conclusion, the Trump administration's decision to stop Medicaid funding for child sex-change hormones and surgeries aims to safeguard children from potential harm and prioritize evidence-based care. The move aligns with the administration's commitment to protecting children and ensuring taxpayer dollars support interventions with proven benefits.